[ad_1]
They discovered a drug that quickly kills COVID-19
The director of the Swedish Division of Drug Infections, Charlotte Bergquist, told Swedish TV TV4 that the introduction of remesivir is currently being studied with “high priority” in the EU and that a decision can be made “in a few days”.
The United States Food and Drug Administration approved the emergency use of remesivir in people hospitalized with severe COVID-19.
Originally, the drug was developed to treat Ebola and is manufactured by California-based Gilead Sciences Inc.
A sensational new list of medications to fight coronavirus.
Clinical trials show that the drug helped shorten recovery time for people who are seriously ill. According to a clinical study conducted under the auspices of the American Institutes of Health, it shortens the average recovery time in patients with COVID-19 from 15 to 11 days.
[ad_2]
